Navigation Links
Interleukin Genetics Announces Conference Call to Discuss Fourth Quarter 2008 Results
Date:2/27/2009

WALTHAM, Mass., Feb. 27 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Alternext US: ILI) announced today that it will host a conference call and Webcast on Monday, March 9, 2009, at 4:30 p.m. EDT to review the Company's fourth quarter and year end 2008 financial results, and provide an update on recent corporate developments.

To access the live call, dial 877-795-3646 (domestic) or 719-325-4833 (international). The live Webcast and replay access of the teleconference will be available on the Investors section of the Company's Website at http://www.ilgenetics.com.

Interleukin Genetics, Inc. (NYSE Alternext US: ILI), is a healthcare company that specializes in the development of genetic biomarker tests for sale to the emerging personalized health market. The Company is focused on the future of health and medicine. Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and commercialize innovative diagnostic and risk assessment genetic tests. These products could help to improve an individual's understanding of needed lifestyle changes or of therapeutic products that can be used to better manage their health. Interleukin Genetics has developed and commercialized genetic tests for risk assessment of coronary artery disease, periodontal disease, and general nutrition. Through its AJG subsidiary, the Company also currently offers an array of Nutraceutical and OTCeuticals(R) products, including Ginkoba(TM), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers. Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics and its ongoing programs, please visit www.ilgenetics.com.


'/>"/>
SOURCE Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
2. Interleukin Genetics Submits Plan to Regain Compliance with Continued Listing Standards
3. Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss
4. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
5. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
6. Interleukin Genetics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
7. Interleukin-12 indicates survival prospects for melanoma patients
8. LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster
9. Interleukin Genetics Reports Fourth Quarter and Year End 2007 Financial Results
10. T cell immunity enhanced by timing of interleukin-7 therapy
11. Interleukin Genetics, Inc. Management to Present at Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... 2017 , ... This morning, more than 275 medical doctors, ... for an independent Vaccine Safety Commission. Five of the signers of the letter, ... a press conference at 9:00 AM Friday, March 31 at the National ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an Atlanta-based dog services provider, ... that assists dog owners in creating legally-enforceable pet trusts for their canine companions. ... next step to protect their new companion. Says Evan Dunbar, CEO of Full Contact ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sports Brand EXOUS Bodygear ... which retails normally at $29.97; for the remaining days of March, the price will ... reduced to a special price of just $10 (regular retail price $19.97). , The ...
(Date:3/29/2017)... ... March 29, 2017 , ... Patients interested in receiving quick ... Dr. Jamie Cameron, with or without a referral. The FASTBRACES system is valued ... on each patient’s case, treatment with the FASTBRACES system could be completed in ...
(Date:3/29/2017)... ... ... Curio Wellness , a premium medical cannabis brand and trusted healthcare partner ... with prominent executives from both inside and outside the cannabis industry. , Joining ... , who has more than twenty years of business leadership and investment experience in ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... , March 30, 2017  Purcell Julie & Lefkowitz LLP, ... is investigating a potential breach of fiduciary duty claim involving ... SGYP ). If you are a ... information regarding this investigation, free of charge, please visit us ... ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... ... chromatograph market to grow at a CAGR of 5.20% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:3/29/2017)... -- Research and Markets has announced the addition of the ... Forecast" report to their offering. ... Proton Therapy Market in Italy will ... There are currently three proton therapy centers in Italy ... Italy , the first patients were treated with proton ...
Breaking Medicine Technology: